Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 929-915-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
LLNA: Skin sensitizing Cat. 1B
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: 16/0438-1, Batch 360-71-3
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature - Species:
- mouse
- Strain:
- CBA
- Remarks:
- CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Envigo RMS B.V., Inc. Postbus 6174, 5960 AD Horst, The Netherlands
- Females (if applicable) nulliparous and non-pregnant: not specified
- Age at study initiation: 8 weeks
- Weight at study initiation: 17.9 - 19.4 g (pretest), 17.9 - 20.6 g (main test)
- Housing: Polycarbonate cages type MII with mesh wire tops (Becker Co.)
- Diet (e.g. ad libitum): Kliba mouse/rat maintenance diet "GLP" supplied by Provimi Kliba SA; ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days before the first test substance application
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24°C
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12 / 12
- IN-LIFE DATES: From: Jan 2017 To: April 2017 - Vehicle:
- methyl ethyl ketone
- Concentration:
- 10, 25, 50%
- No. of animals per dose:
- 5
- Details on study design:
- MAIN STUDY
- Irritation/systemic toxicity: Obvious signs of systemic toxicity and/or local inflammation at the application sites were noted for each animal in the raw data.
- Mortality: A check for moribund and dead animals was made twice each workday (beginning and end) and once on Saturdays, Sundays and on public holidays.
- Form of application: Epicutaneous application is simulating dermal contact with the compound which is possible to occur under practical use conditions.
- Application volume: 25µl per ear
- Site of application: dorsal part of both ears
- Frequency of application: 3 consecutive applications (day 0-2) to the same application site
- Body weight determination: Individual body weights on day 0 prior to the first application and on day 5 prior to the sacrifice of the animals.
- 3G Thymidine injection: On study day 5, 20µCi 3H-thymidine in 250µl sterile saline were injected into the tail vein of the mice.
- Section: The animals were sacrificed on study day 5 about 5h after 3H-thymidine injection by cervical dislocation under Isoflurane anesthesia.
- Ear weight: Immediately after the death of each animal, a circular piece of tissue was punched out of the apical part of each ear of all animals. The weight of the pooled punches was determined for each animal. These measurements serve for detecting a potential inflammatory ear swelling.
- Lymph nodes: Immeadiately after removal of the ear punches, the left and right auricular lymph nodes from both sides was determined for each animal.
- Cell count: After weight determination, the pooled lymph nodes of each animal were stored in PBS in an ice water bath until further preparation. A single cell suspension was prepared as soon as possible after dissection by carefully passing the lymph nodes through an iron mesh into 6ml PBS. For determination of cell counts, an aliquot of each suspension was further diluted and cell count was determined using a cell counter.
- Measuremtn of 3H-thymidine: The remaining cell suspensions were washed with PBS and precipitated with 5% TCA. Each precipitate was transferred to scintillation fluid and incorporation of 3H-thymidine into the cells was measured in a ß-scintillation counter.
ANIMAL ASSIGNMENT AND TREATMENT
- Criteria used to consider a positive response: A test item is regarded as a sensitizer in the LLNA if exposure to at least one concentration of the test item results in an incorporation of 3H-thymidine at least 3-fold or greater than that recorded in control mice as indicated by the stimulation index (SI ≥ 3.0). However, the biological relevance of the obtained stimulation indices is considered in conjunction with the other assessed end points (i.e. lymph node cell counts, lymph node weights, ear weights). Hereby, the thresholds used for assessment of cell counts and ear weights are represented by stimulation indices (SI) of 1.5 and 1.25, respectively. If applicable, the EC (estimated concentration) leading to the respective SI values were
calculated by linear or semi-logarithmical regression between the data points directly below and above the SI if possible or by using the two nearest points below or above the SI. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Parameter:
- EC3
- Remarks:
- %
- Value:
- 43.8
- Test group / Remarks:
- Mean
- Parameter:
- SI
- Value:
- 3.63
- Test group / Remarks:
- 50% in MEK (based on Thymidine incorporation)
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- It is concluded that the test item exhibits a skin sensitizing potential in the Murine Local Lymph Node Assay under the test conditions chosen.
The threshold concentration for sensitization induction was >25% <50%. The EC 3 (estimated concentration that leads to the SI of 3.0) for 3H-thymidine incorporation and the EC 1.5 (estimated concentration that leads to the SI of 1.5) for cell count was calculated by linear regression from the results of these concentrations to be 43.8% and 40.9%, respectively. - Executive summary:
The skin sensitizing potential of the test item was assessed by using the radioactive Murine Local Lymph Node Assay. The assay simulates the induction phase for skin sensitization in mice. It determines the response of cells in the auricular lymph nodes to repeated application of the test substance to the dorsal skin of the ears. Groups of 5 female CBA/CaOlaHsd mice each were treated with 10%, 25% and 50% (w/w) preparations of the test substance in methyl ethyl ketone (MEK) or with the vehicle alone. The highest test-substance concentration which could be technically used was a 50% test substance solution.
The study consisted of 3 test groups and 1 control group. Each test animal was treated with 25 μL per ear of the appropriate test-substance preparation applied to the dorsal surfaces of both ears on three consecutive days. The control group was treated with 25 μL per ear of the vehicle alone.
Three days after the last application, 20 μCi 3H-thymidine in 250 μL sterile saline were injected into the tail vein of the mice. About 5 hours after the 3H-thymidine injection, the mice were sacrificed and the auricular lymph nodes were removed. Lymph node response was evaluated by measuring 3H-thymidine incorporation (indicator of cell proliferation). Cell counts and weights of each animal’s pooled lymph nodes were also determined. In addition, a 0.8 cm diameter sample was punched out of the apical part of each ear and for each animal the weight of the pooled punches was determined to obtain an indication of possible skin irritation.
The mean stimulation indices (expressed as multiples of the vehicle control) for 3H-thymidine incorporation, cell count, lymph node weight and ear weight are summarized for each test group in the table below.
No signs of systemic toxicity were noticed in all animals during general observation. When applied as 50% preparation in MEK, the test substance induced a biologically relevant (increase above the cut-off Stimulation Index of 3) and statistically significant increase of 3H-thymidine incorporation into the cells from the auricular lymph nodes.
Concomitantly, the 50% test-substance preparation induced a biologically relevant and statistically significant response (increase to 1.5-fold or above of control value = stimulation index (SI) ≥ 1.5) in the auricular lymph node cell counts.
In addition, a statistically significant and biologically relevant increase in lymph node weights was noted at the 50% concentration.
All test-substance concentrations did not cause biologically relevant increases (SI > 1.25) in ear weights demonstrating the absence of relevant ear skin irritation. However, a statistically significant increase in ear weights was noted at the 50% concentration but well below the cutoff value.
In addition, very slight erythema and/or slight swelling of the ear skin were observed in all animals at the 50% and 25% concentrations during the observation period. Slight compound residues were noted in all animals of the 50% concentration on study day 2, only.
Thus, it is concluded that the test item exhibits a skin sensitizing potential in the Murine Local Lymph Node Assay under the test conditions chosen.
The threshold concentration for sensitization induction was >25% <50%. The EC 3 (estimated concentration that leads to the SI of 3.0) for 3H-thymidine incorporation and the EC 1.5 (estimated concentration that leads to the SI of 1.5) for cell count was calculated by linear regression from the results of these concentrations to be 43.8% and 40.9%, respectively.
Reference
Pre-Test / Irritation Screening:
No signs of systemic toxicity were observed in the pretest. At the tested concentrations, the animals did not show relevant signs of local irritation as confirmed by determination of the ear weights (compared to current vehicle values) and ear thickness measurements. At the 50% concentration, slight compound residues on the ear skin and/or slight pull out of hair at the head were noted during the observation period.
Main test:
When applied as 50% preparation in MEK, the test substance induced a biologically relevant (increase above the cut-off Stimulation Index of 3) and statistically significant increase of 3H-thymidine incorporation into the cells from the auricular lymph nodes. Concomitantly, the 50% test-substance preparation induced a biologically relevant and statistically significant response (increase to 1.5-fold or above of control value = stimulation index (SI) ≥ 1.5) in the auricular lymph node cell counts. In addition, a statistically significant and biologically relevant increase in lymph node weights was noted at the 50% concentration.
All test-substance concentrations did not cause biologically relevant increases (SI > 1.25) in ear weights demonstrating the absence of relevant ear skin irritation. However, a statistically significant increase in ear weights was noted at the 50% concentration but well below the cutoff value.
No relevant influence on the body weights was observed during the study.
No signs of systemic toxicity were noticed in all animals during general observation.
During the observation period very slight erythema and/or slight swelling of the ear skin were observed in all animals at the 50% and 25% concentrations. Slight compound residues were noted in all animals of the 50% concentration on study day 2, only.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
The skin sensitizing potential of the test item was assessed by using the radioactive Murine Local Lymph Node Assay. The assay simulates the induction phase for skin sensitization in mice. It determines the response of cells in the auricular lymph nodes to repeated application of the test substance to the dorsal skin of the ears. Groups of 5 female CBA/CaOlaHsd mice each were treated with 10%, 25% and 50% (w/w) preparations of the test substance in methyl ethyl ketone (MEK) or with the vehicle alone. The highest test-substance concentration which could be technically used was a 50% test substance solution.
The study consisted of 3 test groups and 1 control group. Each test animal was treated with 25 μL per ear of the appropriate test-substance preparation applied to the dorsal surfaces of both ears on three consecutive days. The control group was treated with 25 μL per ear of the vehicle alone.
Three days after the last application, 20 μCi 3H-thymidine in 250 μL sterile saline were injected into the tail vein of the mice. About 5 hours after the 3H-thymidine injection, the mice were sacrificed and the auricular lymph nodes were removed. Lymph node response was evaluated by measuring 3H-thymidine incorporation (indicator of cell proliferation). Cell counts and weights of each animal’s pooled lymph nodes were also determined. In addition, a 0.8 cm diameter sample was punched out of the apical part of each ear and for each animal the weight of the pooled punches was determined to obtain an indication of possible skin irritation.
The mean stimulation indices (expressed as multiples of the vehicle control) for 3H-thymidine incorporation, cell count, lymph node weight and ear weight are summarized for each test group in the table below.
No signs of systemic toxicity were noticed in all animals during general observation. When applied as 50% preparation in MEK, the test substance induced a biologically relevant (increase above the cut-off Stimulation Index of 3) and statistically significant increase of 3H-thymidine incorporation into the cells from the auricular lymph nodes.
Concomitantly, the 50% test-substance preparation induced a biologically relevant and statistically significant response (increase to 1.5-fold or above of control value = stimulation index (SI) ≥ 1.5) in the auricular lymph node cell counts.
In addition, a statistically significant and biologically relevant increase in lymph node weights was noted at the 50% concentration.
All test-substance concentrations did not cause biologically relevant increases (SI > 1.25) in ear weights demonstrating the absence of relevant ear skin irritation. However, a statistically significant increase in ear weights was noted at the 50% concentration but well below the cutoff value.
In addition, very slight erythema and/or slight swelling of the ear skin were observed in all animals at the 50% and 25% concentrations during the observation period. Slight compound residues were noted in all animals of the 50% concentration on study day 2, only.
Thus, it is concluded that the test item exhibits a skin sensitizing potential in the Murine Local Lymph Node Assay under the test conditions chosen.
The threshold concentration for sensitization induction was >25% <50%. The EC 3 (estimated concentration that leads to the SI of 3.0) for 3H-thymidine incorporation and the EC 1.5 (estimated concentration that leads to the SI of 1.5) for cell count was calculated by linear regression from the results of these concentrations to be 43.8% and 40.9%, respectively.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the results of the LLNA and according to the EC Directive (No. 93/21/EEC) and CLP (No. 1272/2008 of 16th December 2008), the test substance has to be classified regarding skin sensitization (Cat. 1B).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.